The global market for microfluidic pumps is experiencing significant growth, driven by increased investment in research and development within the life sciences and pharmaceutical sectors, coupled with a rising demand for point-of-care testing. Projections indicate that the global micropump market is poised to reach a valuation of USD 3.18 billion by the year 2023. The surge in point-of-care testing, recognized for its efficacy in drug and medication delivery, has amplified the need for precision and efficiency in drug administration, thereby fostering an increased demand for micropumps on a global scale.
A key contributor to the expansion of the micropump market is the escalating utilization of these devices in pharmaceutical, medical, and diagnostic applications. This trend underscores the versatile applications of micropumps in diverse sectors, further enhancing their market presence. Among the various types of micropumps, mechanical micropumps currently dominate the market, holding the largest share. The mechanical micropump segment is anticipated to exhibit a robust Compound Annual Growth Rate (CAGR) of 19.17% from 2017 to 2023.
However, as the micropump market continues to thrive, it faces certain challenges that warrant attention. One such challenge is the adherence to stringent regulatory requirements, which may act as a decelerating factor for market growth. Meeting and complying with regulatory standards can be a complex undertaking, influencing the pace at which the micropump market expands. Additionally, the market contends with challenges related to geometrical and surface chemistry issues, which can impact the overall efficacy and performance of micropumps.
Despite these challenges, the micropump market remains buoyant, primarily fueled by the relentless advancements in life sciences and pharmaceuticals. The demand for precise and efficient drug delivery mechanisms, coupled with the expanding applications of micropumps in various sectors, contributes to the market's resilience. The continued focus on research and development activities, coupled with technological innovations, is expected to address existing challenges and propel the micropump market towards sustained growth in the coming years.
In conclusion, the global micropump market is witnessing robust growth driven by factors such as increased R&D investment, a rising demand for point-of-care testing, and the versatile applications of micropumps in pharmaceutical, medical, and diagnostic domains. While challenges exist, the market's ability to navigate and overcome these hurdles underscores its potential for long-term expansion and development.
Report Attribute/Metric | Details |
---|---|
Market Size Value In 2022 | USD 2.1 Billion |
Market Size Value In 2023 | USD 2.50 Billion |
Growth Rate | 19.20% (2023-2032) |
Micropump Market Size was valued at USD 2.1 Billion in 2022. The Micropump market industry is projected to grow from USD 2.50 Billion in 2023 to USD 10.20 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 19.20% during the forecast period (2023 - 2032). Increase in chronic illnesses such as cancer and diabetes, technological advancements in the healthcare industry, and increased knowledge of regulated medication administration are the key market drivers enhancing the market growth.
Source Secondary Research, Primary Research, MRFR Database and Analyst Review
Market CAGR for micropump is being driven by the rising use in medical industry. The increasing number of pharmaceutical enterprises, increased research and development in life sciences, the creation and implementation of clinical testing, and the widespread usage of the micro-pump in infusion treatment are the primary drivers driving the lucrative market expansion. Micro-Pumps have grown rapidly due to research into numerous approaches, the available raw materials needed for manufacture, and advancements in digital and electronic capabilities. Furthermore, the number of innovations in this product category has increased, which is supporting the rise of items in this area. The increasing number of pharmaceutical enterprises, increased research and development in life sciences, the creation and implementation of clinical testing, and the widespread usage of the micro-pump in infusion treatment are the primary drivers driving the lucrative market expansion.
Micro-Pumps have grown rapidly due to research into numerous approaches, the available raw materials needed for manufacture, and advancements in digital and electronic capabilities. In recent years, controlled drug release has presented various obstacles, such as releasing the appropriate amount of medications at the correct time with the least amount of invasiveness and increasing demand for improved drug delivery systems. Long-term treatments, tight therapeutic windows, complex dosage schedules, combination therapies, and customized dosing regimens are some elements that challenge traditional drug delivery systems. Micro-electro-mechanical systems (MEMS), which mix mechanical and electrical components, are emerging to remedy these problems.
The increasing acceptance of miniaturized medical equipment has contributed to reshaping the medical device sector. Because of escalating healthcare expenses and the transition to home-based outpatient treatment, the need for smaller, lighter, and more portable devices has skyrocketed. A medical device may be miniaturized in various methods, the most important of which is through micropumps. Micropumps have reduced production costs, fewer leaks, lower power consumption, and more precision due to the regulated flow of fluids and medicine doses into the body. They can efficiently manage extremely tiny amounts of liquid. Micropumps are being developed for various medical End Users, including transdermal insulin administration, artificial heart blood transportation, glucose and medication injection, hormone therapy, and pain and wound-care management. Thus, driving the Micropump market revenue.
Based on type, the Micropump market segmentation includes mechanical micropump, piezoelectric micropump, syringe pumps, peristaltic pump and non-mechanical micropump. The mechanical micropump segment dominated the market, accounting for 35% of market revenue. This is because mechanical micro-pumps are used in Micro-Electro-Mechanical Systems (MEMS). MEMS is employed in drug delivery system vehicles because they are inexpensive, simple to use, capable of monitoring illnesses and allow quick detection and administration of medications.
Based on material, the Micropump market segmentation includes polymer, glass and silicon. The silicon segment dominated the market. This is because the manufacture of mechanical micropump technology now significantly relies on silicon-based micromachining processes. Furthermore, silicon micromachining provides various benefits that make it easier to apply in high-performance applications like drug distribution.
The Micropump market segmentation, based on application includes drug delivery systems, medical device and in-vitro diagnostics. The drug delivery systems segment dominated the market. This is due to the growing usage of micro-pumps in implanted medication delivery systems. The in-vitro diagnostic industry is predicted to grow fast as micro-Pumps are utilized for early illness diagnosis, simpler monitoring, and improved customization. There have also been several advancements in wearable medical devices that employ micro-Pumps to transfer micro-fluids.
Based on End Users, the Micropump market segmentation includes biotechnology and pharmaceutical companies, hospitals, diagnostic centers, and research institutes. The biotechnology and pharmaceutical companies categories generated the most income. Increasing R&D has resulted in increasing demand for micro-Pumps, contributing to the market share of biotechnology and pharmaceutical firms.
Figure 1 Micropump Market, by End User, 2022 & 2032 (USD Billion)
Source Secondary Research, Primary Research, MRFR Database and Analyst Review
Micropump Regional Insights
By region, the study provides market insights into North America, Europe, Asia-Pacific and the Rest of the World. The Asia Pacific Micropump market area will dominate this market because of its growing quality healthcare infrastructure, competent staff, increased awareness of healthcare goods, increase in point-of-care diagnostic centers, and rigorous research and development programs.
Further, the major countries studied in the market report are The US, Canada, German, India, Australia, France, the UK, Italy, Spain, China, Japan, South Korea, and Brazil.
Figure 2 MICROPUMP MARKET SHARE BY REGION 2022 (USD Billion)
Source Secondary Research, Primary Research, MRFR Database and Analyst Review
North America has the second-largest Micropump Material market share. High buying power, strong government backing for high-quality healthcare, high-quality clinical and laboratory research infrastructure, and widespread acceptance of technologically sophisticated goods are just a few of the factors propelling regional market growth. Furthermore, the US Micropump Material market dominated, while the Canada Micropump Material market grew fastest in North America.
From 2023 to 2032, the Europe Micropump Material Market will develop at the quickest CAGR. Due to economic development, Asian-Pacific inhabitants' increasing per capita income has increased spending on semiconductor-based equipment and products such as cell phones, personal computers, high-definition (HD) television sets, and others. Furthermore, the German Micropump Material market had the highest market share, whereas the UK was Europe's fastest-growing market.
Micropump Material Key Market Players & Competitive Insights
Leading market companies are extensively spending R&D on increasing their product lines, which will help the Micropump Material market grow even more. Important market developments include new product releases, contractual agreements, acquisitions and mergers, greater investments, and collaboration with other organizations. The Micropump Material industry must produce cost-effective merchandise to flourish and thrive in a more competitive and increasing market climate.
Manufacturing locally to reduce operating costs is an effective business strategy manufacturers use in the worldwide Micropump Material industry to serve clients and expand the market sector. The Micropump Material industry has recently provided some of the most important benefits. LEE Ventus (previously TTP Ventus) , LEE Plug and other major competitors in the Micropump Material market seek to improve market demand by investing in R&D efforts.
The Lee Plug, a device created to meet a specific client need, was the Lee Company's first product. They have continued producing and developing new, inventive, and pioneering solutions to customers' concerns in the 70+ years since this creation.They are the original creators of hundreds of unique tiny fluid control products and technologies that have been - and continue to be - used in everything from automobiles and planes to medical gadgets that assist in identifying and curing ailments. They also play crucial roles in satellites hundreds of miles away in orbit and oil wells kilometers below the earth's surface. The Lee Company takes pleasure in addressing our industry's most difficult difficulties. In March 2020, The Lee Company collaborated with General Motors and Ventec Life Systems to mass-produce crucial COVID-19 ventilators. In just 154 days, the firms supplied 30,000 V+ Pro ventilators. More diagnostics and other emergency care services were necessary as the number of patients increased.
In Cambridge, UK, LEE Ventus (previously TTP Ventus) manufactures and tests the Disc Pump family of multi-award-winning piezoelectric micropumps. LEE Ventus is a division of The Lee Company, a leading precision fluidics company headquartered in Connecticut, USA.Their pumps provide high pressure and flow, silent operation, quick reaction time, accuracy, and ultra-smooth flow in a small compact. Their objective is to deliver high-performance products and great development support to clients to promote innovation across industries ranging from medical and life sciences to environmental and industrial via advancements in wearability, portability, and simplicity. In June 2019, TTP Ventus Ltd. has introduced a new line of pumps that improve performance by offering higher flow rates, higher pressures, and longer lives. This brings up new opportunities for product creation in areas such as microfluidics research, medical diagnostics, therapeutic devices, and wearables.
Key Companies in the Micropump market include
Micropump Industry Developments
March 2022 Medtronic plc has announced the availability of the MiniMed 780G system in India. The MiniMed 780G system is a next-generation closed-loop insulin pump device used to treat type 1 diabetes in patients aged 7 to 80. The device, which incorporates the company's most sophisticated SmartGuard technology, automates the delivery of both basal insulin and corrective boluses every five minutes, allowing people with diabetes to avoid highs and lows with more ease.
January 2022 Bartels Mikrotechnik GmbH, Inc introduced the mp6 family of micro-pumps. The mp6 series includes the mp6-Liq, mp6-gas, and mp6-gas+ models.
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)